

Prof Angela Tincani
Professor Angela Tincani is a senior consultant (previously director) at the Rheumatology and Clinical Immunology Unit of Aziende Socio Sanitaria Territoriali (ASST)-Spedali Civili and University of Brescia, Italy.
Professor Tincani has been involved in several international committees for education and research in the field of systemic autoimmune diseases. Professor Tincani’s primary clinical and research interests include the use of anti-rheumatic drugs in pregnant and lactating patients and the management of pregnancy in rheumatic disease patients, in addition to evaluating autoantibodies and autoimmune diseases as risk factors for poor gestational outcomes. She served as an expert for several European Alliance of Associations for Rheumatology (EULAR) recommendations, including “Points to consider for use of anti-rheumatic drugs before pregnancy and during pregnancy and lactation”. Together with Professor Andreoli, Professor Tincani is co-principal investigator of the “Italian Registry of Pregnancy in Rheumatic Diseases”.
This infographic outlines the six proposed stages of HS pathogenesis and highlights the immune cells involved in the progression of HS
The symptoms of HS go beyond skin deep. For the true burden of HS and to facilitate holistic care, see the full list of symptoms that patients may experience
Can you spot the signs and symptoms of HS? Take a look at our algorithm that aims to aid a diagnosis of HS
Developed with input from HS experts, this guide provides practical information to help you successfully recognize, manage and communicate with patients
Did you know that gender influences the quality of life of a patient with psoriasis1 ? This material highlights the specific needs that women living with...
Did you know that 50% of pregnancies are unplanned?1
This material presents a summary of why timely discussions about family planning between healthcare...